Phase I/II Gene Therapy Trial of Fanconi anemia patients with a new Orphan Drug consisting of a lentiviral vector carrying the FANCA gene: A Coordinated International Action

Project Information

EUROFANCOLEN

Grant agreement ID: 305421

Project closed

Start date 1 January 2013

End date 31 December 2018

Funded under

• Specific Programme "Cooperation": Health

Total cost € 7 014 945,20

EU contribution € 5 380 169,75

Coordinated by

CENTRO DE INVESTIGACIONES ENERGETICAS MEDIOAMBIENTALES Y TECNOLOGICAS
Spain